A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration

Saved in:
Bibliographic Details
Published inKidney international Vol. 102; no. 5; pp. 1188 - 1190
Main Authors Benotmane, Ilies, Velay, Aurélie, Vargas, Gabriela Gautier, Olagne, Jérôme, Cognard, Noëlle, Heibel, Francoise, Braun-Parvez, Laura, Martzloff, Jonas, Perrin, Peggy, Pszczolinski, Romain, Moulin, Bruno, Fafi-Kremer, Samira, Caillard, Sophie
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2022
International Society of Nephrology. Published by Elsevier Inc
Subjects
COVID-19
Humans
Immunoglobulin G
Kidney Transplantation - adverse effects
Letter to the Editor
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Online AccessGet full text
ISSN0085-2538
1523-1755
1523-1755
DOI10.1016/j.kint.2022.07.022

Cover

More Information
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:0085-2538
1523-1755
1523-1755
DOI:10.1016/j.kint.2022.07.022